// App-Quantinova.ai

TCT-642 : PARIS Risk Score Stratified Analysis of Clinical Outcomes Among Elderly Patients (Aged > 75 Years) Treated With 23-Month Ticagrelor Monotherapy Following 1-Month DAPT After PCI in the GLOBAL LEADERS Trial

Researchers

Presenter

  • Mariusz Tomaniak

Principal Investigators

  • Rodrigo Modolo

  • Kuniaki Takahashi

  • Norihiro Kogame

  • Chun-Chin Chang

  • Ernest Spitzer

  • Robert-Jan van Geuns

  • Tobias Geisler

  • Janusz Prokopczuk

  • Manel Sabate

  • Tessa Rademaker-Havinga

  • Christian Hamm

  • Yoshinobu Onuma

  • Pascal Vranckx

  • Marco Valgimigli

  • Stephan Windecker

  • Usman Baber

  • Richard Anderson

  • Marcello Dominici

  • Patrick Serruys

Medical Centers

  • Swiss Cardiovascular Center, Inselpsital, Bern, Switzerland

  • Kerckhoff Clinic, Bad Nauheim, Germany

  • Imperial College, Rotterdam, the Netherlands

  • Cardialysis, Rotterdam, the Netherlands

  • University Hospital of Wales, Cardiff, United Kingdom

  • S. Maria University Hospital, Narni, Terni, Italy

  • UNIVERSITY HOSPITAL TUEBINGEN, Tuebingen, Germany

  • PAKS Kędzierzyn-Koźle, Kędzierzyn-Koźle, Poland

  • Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA

  • Thorax Center, Erasmus MC, Department of Interventional Cardiology, Rotterdam, Netherlands, Medical University of Warsaw, First Department of Cardiology, Warsaw, Poland

  • Academic Medical Center, Amsterdam, Netherlands

  • Radboud University Medical Center, Njmegen, Netherlands

  • Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland

  • Hartcentre Hasselt, Hasselt, Belgium

Locations

  • Switzerland

  • Netherlands

  • United Kingdom

  • Germany

  • United States

  • Italy

  • Poland

  • Spain

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final